Recent Advances in Cardiovascular Drug Discovery (Discontinued)
,Volume 10
-Number 1
Meet Our Editorial Board Member
Preface
Preface: Facing New Challenges in Cardiovascular Disease, When the Pressure Goes Up and the Pump Goes Astray
, 10(1): 2 - 3Raouf A Khalil
DOI: 10.2174/157489011001160111165714
Preface: Facing New Challenges in Cardiovascular Disease, When the Pressure Goes Up and the Pump Goes Astray
Hypertension in Type 2 Diabetes Mellitus: Do We Need to Redefine the Role of Sulfonylureas?
, 10(1): 4 - 9Devindra Sehra and Sudhish Sehra
DOI: 10.2174/157489011001160111154536
Hypertension in Type 2 Diabetes Mellitus: Do We Need to Redefine the Role of Sulfonylureas?
Basic and Clinical Research Against Advanced Glycation End Products (AGEs): New Compounds to Tackle Cardiovascular Disease and Diabetic Complications
, 10(1): 10 - 33Antonio Nenna, Cristiano Spadaccio, Mario Lusini, Luca Ulianich, Massimo Chello and Francesco Nappi
DOI: 10.2174/1574890110666151104120039
Basic and Clinical Research Against Advanced Glycation End Products (AGEs): New Compounds to Tackle Cardiovascular Disease and Diabetic Complications
The Challenges of Blood Pressure Control in Dialysis Patients
, 10(1): 34 - 59Vito M. Campese and Ravi Lakdawala
DOI: 10.2174/1574890110666151116144725
The Challenges of Blood Pressure Control in Dialysis Patients
NOAC or warfarin for Atrial Fibrillation: does time in therapeutic range matter?
, 10(1): 60 - 64Ioannis Merinopoulos, Paul Venables, Isobel Chalmers and Vassilios Vassiliou
DOI: 10.2174/1574890110666150914121856
NOAC or warfarin for Atrial Fibrillation: does time in therapeutic range matter?
Combination of Vasopressin –Epinephrine as a Novel Candidate in Patients with Cardiac Arrest
, 10(1): 65 - 69Nasim Ghafourian, Nader H. Maniae, Morovat Taherikalani, Maryam Mehrazi, Mahnaz Hossieni, Firouzeh Valian, Shahriar Karami, Yazdan Rahmatian and Nader Tavakoli
DOI: 10.2174/157489011001160111163856
Combination of Vasopressin –Epinephrine as a Novel Candidate in Patients with Cardiac Arrest
Cardiovascular Implantable Electronic Device Infections: Risk Scoring and Role of Antibiotic Envelope in Prevention
, 10(1): 70 - 76Nasir Shariff, Tauseef Akthar, Eathar Razak, Nathan Segerson and David Schwartzman
DOI: 10.2174/1574890110666151104120207
Cardiovascular Implantable Electronic Device Infections: Risk Scoring and Role of Antibiotic Envelope in Prevention
Hypertension in Type 2 Diabetes Mellitus: Do We Need to Redefine the Role of Sulfonylureas?
, 2015; 10(1): 4 - 9Devindra Sehra and Sudhish Sehra
DOI: 10.2174/157489011001160111154536
Anti-VEGF Anticancer Drugs: Mind the Hypertension
, 2014; 9(2): 63 - 72Vasiliki Katsi, Zerdes Ioannis*, Manolakou Stavroula, Makris Thomas, Nihoyannopoulos Petros, Tousoulis Dimitris and Kallikazaros Ioannis
DOI: 10.2174/1574890110999150604114127
Webmaster Contact: info@benthamscience.org